Yubo International Biotech Ltd (YBGJ) › Operating IncomeYubo International Biotech Ltd (YBGJ) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2011: -$80.0K2012: -$47.0K2013: -$60.0K2014: -$55.0K2015: -$58.0K2016: -$63.0K2017: -$149.0K2018: -$58.0K2019: -$48.0K2020: -$711.8K2021: -$1.54M2022: -$1.21M2023: -$1.19M2024: -$1.77M2025: -$1.19M-$1.19M2011Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$1.19M+32.9%2024-$1.77M-48.1%2023-$1.19M+0.9%2022-$1.21M+21.9%2021-$1.54M-116.8%2020-$711.8K-1382.9%2019-$48.0K+17.2%2018-$58.0K+61.1%2017-$149.0K-136.5%2016-$63.0K-8.6%2015-$58.0K-5.5%2014-$55.0K+8.3%2013-$60.0K-27.7%2012-$47.0K+41.2%2011-$80.0K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share